Elagib K E, Børretzen M, Vatn I, Natvig J B, Thompson K M
Laboratory for Rheumatology Research, Institute of Immunology, The National Hospital, 0027 Oslo, Norway.
Clin Immunol. 2001 Jan;98(1):62-9. doi: 10.1006/clim.2000.4951.
To investigate the genetic background of anti-F(ab')(2) autoantibodies and the mechanism behind their production we have analyzed 10 human monoclonal antibodies directed against IgG F(ab')(2) and IgG Fab. They were all derived from peripheral blood by the EBV/hybridoma technique. Eight were from three healthy individuals and two from two patients with primary Sjögren's syndrome (pSS). They react with epitopes on distinct regions of IgG, including epitopes present on or near the hinge of IgG, epitopes on the Fd gamma, and an antigenic determinant(s) present on lambda light chains. These determinants are either exposed on the intact IgG molecule or revealed following pepsin or papain digestion. The V(H) germline gene repertoire used is diverse and with considerable overlap with that used by rheumatoid factors (RF). The two IgG antibodies from normals are extensively mutated (13 and 24 mutations/V(H)), but with a replacement to silent mutation ratio in the CDR(H)1 + 2 of only 3.7. The IgM antibodies from normals are also heavily mutated (mean 10 mutations/V(H)). This suggests that anti-F(ab')(2) from normals are generated by an antigen-driven somatic hypermutation mechanism. In contrast, the two IgM antibodies from pSS are virtually unmutated in both V(H) and V(L). Together with published data of pSS RF and anti-Ro 52-kDa sequences (1-3), this suggests that there is an expanded population of naïve B cells with autoantibody specificities in the peripheral blood of pSS patients.
为了研究抗F(ab')(2)自身抗体的遗传背景及其产生机制,我们分析了10种针对IgG F(ab')(2)和IgG Fab的人单克隆抗体。它们均通过EBV/杂交瘤技术从外周血中获得。其中8种来自3名健康个体,2种来自2名原发性干燥综合征(pSS)患者。它们与IgG不同区域的表位发生反应,包括IgG铰链区或其附近的表位、Fdγ上的表位以及λ轻链上存在的一个或多个抗原决定簇。这些决定簇要么暴露在完整的IgG分子上,要么在胃蛋白酶或木瓜蛋白酶消化后暴露出来。所使用的V(H)胚系基因库具有多样性,且与类风湿因子(RF)所使用的基因库有相当大的重叠。来自正常人的两种IgG抗体发生了广泛的突变(13和24个突变/V(H)),但在CDR(H)1 + 2中替换突变与沉默突变的比例仅为3.7。来自正常人的IgM抗体也有大量突变(平均10个突变/V(H))。这表明正常人的抗F(ab')(2)是通过抗原驱动的体细胞超突变机制产生的。相比之下,来自pSS患者的两种IgM抗体在V(H)和V(L)中几乎没有突变。结合已发表的pSS RF和抗Ro 52-kDa序列的数据(1-3),这表明pSS患者外周血中具有自身抗体特异性的幼稚B细胞群体有所扩大。